Quessada, J. et al. Cytogenetics of pediatric acute myeloid leukemia: a review of the current knowledge. Genes (Basel) 12, https://doi.org/10.3390/genes12060924 (2021).

Slats, A. M. et al. Causes of death—other than progressive leukemia—in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhoold Oncology Group experience. Leukemia 19, 537–544 (2005).

Article  CAS  PubMed  Google Scholar 

Zwaan, C. M. et al. Collaborative efforts driving progress in pediatric acute myeloid leukemia. J. Clin. Oncol. 33, 2949–2962 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bolouri, H. et al. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. Nat. Med. 24, 103–112 (2018).

Article  CAS  PubMed  Google Scholar 

Elgarten, C. W. & Aplenc, R. Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy. Curr. Opin. Pediatr. 32, 57–66 (2020).

Article  PubMed  Google Scholar 

Conneely, S. E. & Stevens, A. M. Acute myeloid leukemia in children: emerging paradigms in genetics and new approaches to therapy. Curr. Oncol. Rep. 23, https://doi.org/10.1007/s11912-020-01009-3 (2021).

Nunes, A. et al. Cytogenetic abnormalities, WHO classification, and evolution of children and adolescents with acute myeloid leukemia. Hematol. Transfus. Cell Ther. 41, 236–243 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Sandahl, J. D. et al. The applicability of the WHO classification in paediatric AML. A NOPHO-AML study. Br. J. Haematol. 169, 859–867 (2015).

Article  PubMed  Google Scholar 

Lonetti, A., Pession, A. & Masetti, R. Targeted therapies for pediatric AML: gaps and perspective. Front. Pediatr. 7, 1–11 (2019).

Article  Google Scholar 

Morris, K. V. & Mattick, J. S. The rise of regulatory RNA. Nat. Rev. Genet. 15, 423–437 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anelli, L., Zagaria, A., Specchia, G., Musto, P. & Albano, F. Dysregulation of miRNA in leukemia: exploiting miRNA expression profiles as biomarkers. Int. J. Mol. Sci. 22, https://doi.org/10.3390/ijms22137156 (2021).

de Carvalho, I. N. S. R., de Freitas, R. M. & Vargas F. R. Translating microRNAs into biomarkers: what is new for pediatric cancer? Med. Oncol. 33, https://doi.org/10.1007/s12032-016-0766-4 (2016).

Liu, Y. et al. Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia. J. Hematol. Oncol. 12, 1–20 (2019).

Article  Google Scholar 

Narayan, N. et al. Functionally distinct roles for different miR-155 expression levels through contrasting effects on gene expression, in acute myeloid leukaemia. Leukemia 31, 808–820 (2017).

Article  CAS  PubMed  Google Scholar 

Qi, X. & Zhang, Y. MicroRNA-199a deficiency relates to higher bone marrow blasts, poor risk stratification and worse prognostication in pediatric acute myeloid leukemia patients. Pediatr. Hematol. Oncol. 39, 500–507 (2022).

Article  CAS  PubMed  Google Scholar 

Liu, H., Wu, H. & Qin, X. MicroRNA-206 serves as a tumor suppressor in pediatric acute myeloid leukemia by targeting Cyclin D1. Pathol. Res. Pract. 215, https://doi.org/10.1016/J.PRP.2019.152554 (2019).

Emmrich, S. et al. miR-139-5p controls translation in myeloid leukemia through EIF4G2. Oncogene 35, 1822–1831 (2016).

Article  CAS  PubMed  Google Scholar 

Daschkey, S. et al. MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways. PLoS ONE 8, 1–16 (2013).

Article  Google Scholar 

Yan, W. et al. MicroRNA biomarker identification for pediatric acute myeloid leukemia based on a novel bioinformatics model. Oncotarget 6, 26424–26436 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Obulkasim, A. et al. Classification of pediatric acute myeloid leukemia based on miRNA expression profiles. Oncotarget 8, 33078–33085 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Vanhooren, J. et al. Deciphering the non-coding RNA landscape of pediatric acute myeloid leukemia. Cancers (Basel) 14, https://doi.org/10.3390/cancers14092098 (2022).

Kumar, S. & Bakhshi, S. Diagnostic & prognostic role of microRNAs in paediatric acute myeloid leukaemia. Indian J. Med. Res. 144, 807 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ng, S. W. K. et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature 540, 433–437 (2016).

Article  CAS  PubMed  Google Scholar 

Elsayed, A. H. et al. A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia. Leukemia 34, 735–745 (2020).

Article  CAS  PubMed  Google Scholar 

Shi, H., Gao, L., Zhang, W. & Jiang, M. Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients. BMC Bioinform. 23, https://doi.org/10.1186/S12859-022-04841-5 (2022).

Esperanza-Cebollada, E. et al. A miRNA signature related to stemness identifies high-risk patients in paediatric acute myeloid leukaemia. Br. J. Haematol. 202, https://doi.org/10.1111/BJH.18746 (2023).

Zebisch, A. & Sill, H. How do non-coding RNAs impact treatment regimens currently being used in AML? Expert Rev. AntiCancer Ther. 22, 331–333 (2022).

Article  CAS  PubMed  Google Scholar 

Zhu, R. et al. A 4-microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia. J. Cell. Biochem. 120, 3958–3968 (2019).

Article  CAS  PubMed  Google Scholar 

Zhu, R. et al. A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia. Oncotarget 8, 38902–38913 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Lim, E. L. et al. MicroRNA expression-based model indicates event-free survival in pediatric acute myeloid leukemia. J. Clin. Oncol. 35, 3964–3977 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang, P., Sun, D., Sun, X. & Li, H. Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia. Eur. J. Med. Res. 25, https://doi.org/10.1186/S40001-020-00442-1 (2020).

Bhayadia, R. et al. Endogenous tumor suppressor microRNA-193b: therapeutic and prognostic value in acute myeloid leukemia. J. Clin. Oncol. 36, 1007–1016 (2018).

Article  CAS  PubMed  Google Scholar 

Kuai, W., Bai, J., Guo, A. & Hong, Z. Upregulation of microRNA-100 predicts poor prognosis in patients with pediatric acute myeloid leukemia. Onco Targets Ther. 5, 213–219 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Hong, Z., Zhang, R. & Qi, H. Diagnostic and prognostic relevance of serum miR-195 in pediatric acute myeloid leukemia. Cancer Biomark. 21, 269–275 (2018).

Article  CAS  PubMed  Google Scholar 

Wang, Z., Hong, Z., Gao, F. & Feng, W. Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia. Mol. Cell Biochem. 383, 59–65 (2013).

Article  CAS  PubMed  Google Scholar 

Lin, X., Wang, Z., Zhang, R. & Feng, W. High serum microRNA-335 level predicts aggressive tumor progression and unfavorable prognosis in pediatric acute myeloid leukemia. Clin. Transl. Oncol. 17, 358–364 (2015).

Article  CAS  PubMed  Google Scholar 

Lin, X., Wang, Z., Wang, Y. & Feng, W. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia. Int. J. Clin. Exp. Pathol. 8, 14658 (2015).

CAS  PubMed  PubMed Central  Google Scholar 

Zhu, C. et al. Prognostic value of miR-29a expression in pediatric acute myeloid leukemia. Clin. Biochem. 46, 49–53 (2013).

Article  CAS  PubMed  Google Scholar 

Yang, J., Yuan, Y., Yang, X., Hong, Z. & Yang, L. Decreased expression of microRNA-122 is associated with an unfavorable prognosis in childhood acute myeloid leukemia and function analysis indicates a therapeutic potential. Pathol. Res. Pract. 213, 1166–1172 (2017).